• Gianni Biancofiore, Mercedes Susan Mandell, and Giorgio Della Rocca.
• Anestesia e Rianimazione SSN, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy. g.biancofiore@med.unipi.it
• Curr Opin Anaesthesiol. 2010 Apr 1; 23 (2): 128-32.

Purpose Of ReviewThis review aims to identify specific criteria for cirrhotic cardiomyopathy, examine the correlation with perioperative adverse outcomes and explore options for hemodynamic monitoring.Recent FindingsCirrhotic cardiomyopathy is characterized by an increase in cardiac output, blunted systolic contractile response to stress, diastolic dysfunction and electrophysiological abnormalities. Adverse events due to cirrhotic cardiomyopathy are not as well characterized, but evidence suggests that some cardiovascular complications during surgery and in the postoperative period are caused by an impaired response to physiological stress. New developments in hemodynamic monitoring using not only thermodilution technology provide more reliable information about cardiac performance than pressure-derived measures. Transesophogeal echocardiography also offers the physician new information including the ability to visualize heart structures, shape, and function.SummaryTo detect cirrhotic cardiomyopathy, physicians must conduct a systematic examination of the patient. Overt manifestations of cirrhotic cardiomyopathy often only become evident after a patient is exposed to physiological or drug-induced stress. Appropriate hemodynamic monitoring is a cornerstone in the perioperative management of cirrhotic patients.

13 keywords...

hide…